Pesticides: The New Pharma?

Fen-phen, Baycol, Rezulin, Vioxx… The 1990s and 2000s saw a tidal wave of pharmaceutical-related litigation that dominated the agenda of the plaintiffs' bar. Mass torts over the negative health ...

Casualty Underwriting: The Original ESG

Promoting Environmental, Social and Governance (ESG) performance has become a top priority of corporate executives and boards everywhere, including in property and casualty insurance. However, ...

What Do You Do With Emerging Interest Risks?

Every emerging risk strategy must begin with a horizon scan. At Praedicat, our strategy is to scan the scientific literature for indications that scientists are investigating a new hypothesis that ...

Emerging Damage: The Case of Melamine

Emerging risks evolve through three phases: emerging interest, emerging damage and emerging litigation. During the "emerging interest" phase, scientists, regulators or legal scholars first flag the ...

Social Inflation and the Risk of D&O-GL Clash

Social inflation is the primary explanation offered for the need to increase general liability and excess casualty premiums in the last two years. With social inflation, injured parties are more ...

Growing Risk for SME Insurers: Duty to Defend Cats

Until recently, there was a relative lull in new mass tort events in the United States. This led to a sense among insurers that mass litigation was no longer the looming threat that it was in the ...

Liability Long Tail Could Get Longer

One of the most challenging things about liability insurance is that claims on this year's policy might be made well into the future. If exposure to a chemical, product or business activity this year ...